Form 4 for AURA Aura Biosciences, Inc.
Accepted 2023-10-05 00:00:00 ET · period of report 2023-10-03 · accession 0000950170-23-052244 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-10-05 | 2023-10-03+ | AURA | Johnson David Michael | Dir | P - Purchase | $8.38 | +20.1K | 50.1K | +67% | +$168.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-03 | P | A | 13,500 | $8.27 | 43,500 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $8.00 to $8.51, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2023-10-04 | P | A | 6,566 | $8.61 | 50,066 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $8.52 to $8.66, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. |